TRACON Pharmaceuticals, Inc. (TCON)
OTCMKTS
· Delayed Price · Currency is USD
0.0632
+0.0052 (8.97%)
Nov 14, 2024, 2:47 PM EST
TRACON Pharmaceuticals Revenue
TRACON Pharmaceuticals had revenue of $55.00K in the quarter ending June 30, 2024, a decrease of -99.39%. This brings the company's revenue in the last twelve months to $3.20M, down -64.44% year-over-year. In the year 2023, TRACON Pharmaceuticals had annual revenue of $12.05M.
Revenue (ttm)
3.20M
Revenue Growth
-64.44%
P/S Ratio
0.04
Revenue / Employee
188.24K
Employees
17
Market Cap
202.07K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 104.76M |
TRACON Pharmaceuticals News
- 5 weeks ago - Himax Technologies: Navigating The Down Cycle - Seeking Alpha
- 3 months ago - TRACON Pharmaceuticals Announces it Will Wind Down Operations - GlobeNewsWire
- 5 months ago - TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients - GlobeNewsWire
- 6 months ago - TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024 - GlobeNewsWire
- 7 months ago - TRACON Pharmaceuticals Announces Reverse Stock Split - GlobeNewsWire
- 9 months ago - TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript - Seeking Alpha